NEWS
Dr Kristian Sandberg new board member of Lipum
Dr Kristian Sandberg is an associate professor in immunology and an experienced leader in the pharmaceutical industry’s research and development. Sandberg has over 20 years’ experience from AstraZeneca in various functions within R&D, primarily with [...]
Lipum will attend Bio-Europe Spring 2020
In March Lipum will attend Bio-Europe Spring, Europe's largest partnership conference for the biotechnology industry. Meet us there! Visit site: https://informaconnect.com/bioeurope-spring/
Dr Kristian Sandberg suggested as new board member
Press release Februari 18, 2020 The board of directors of Lipum AB has suggested Dr Kristian Sandberg to be elected as new member of the board at an extraordinary general meeting held in Umeå on [...]
Lipum kallar till extra bolagsstämma
Aktieägarna i Lipum AB, org. nr. 556813-5999, kallas härmed till extra bolagsstämma tisdagen den 3 mars 2020, kl. 13:00 på Tvistevägen 48C i Umeå. Styrelsen föreslår att Dr Kristian Sandberg väljs som ordinarie styrelseledamot i [...]
A milestone has been reached
After an intensive and targeted work, the cell line development of our lead drug candidate SOL-116 has been finalized. Now the production optimization and scale up has been initiated and that will provide access of [...]
Professor Anders Fasth joins the scientific advisory board
Press release November 29, 2019 […]
Pharma Outsourcing 2019
“How we selected our CMO partner for cell line and production development of Lipum´s lead candidate drug SOL-116” […]
Lipum in preparation for Bio-Europe
– Our goal is to meet with investors interested in our next financing round, says our CEO Einar Ponten in preparation for Bio-Europe in Hamburg, 11-13 November. […]
BioStock Life Science Summit
Life Science industry leaders, financing experts and qualified investors gather in Lund. Welcome to meet us at Biostock Life Science Summit, october 23th-24th. […]
INVESTOR RELATIONS
